Biotech, Clinical Research, Pharmaceutical News & Jobs

The Wayback Machine - https://web.archive.org/web/20110406082652/http://www.biospace.com:80/

BioSpace Login

Enter your BioSpace account email address and password to log in now.

Email Address

Password

Keep me logged in

Close Window

Forgot Your Password? | Privacy Statement

NEW MEMBER SIGN UP

Display Name

Email Address

Password

Password again

Zip

Country

Close Window

Privacy Statement

Biotech and Pharmaceutical
News & Jobs

Search the Site

Community Login

What is this?

Employers
Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

Wednesday, April 06, 2011

Optimer Pharmaceuticals, Inc. (OPTR) Wins FDA Advisory Panel's Backing for Fidaxomicin for Treatment of Patients With Clostridium difficile Infection (CDI) More...

Merck & Co., Inc. (MRK) to Acquire Inspire Pharmaceuticals, Inc. (ISPH) for $430 Million More...

Royalty Pharma Acquires Lexiscan(R) and Cubicin(R) Royalties for $487 Million More...

Bayer HealthCare (BAY) Unit Consolidating in N.J., Adding 500 Jobs More...

Trading Halted Today in Optimer Pharmaceuticals, Inc. (OPTR)'s Stock; FDA Advisory Committee Reviewing Fidaxomicin Data in Clostridium difficile Infection More...

Early-Stage Genentech (RHHBY) Cancer Drug Combo Shows Promise More...

FDA Approves Boehringer Ingelheim Corporation's One-Pill, Once-Daily Viramune(R) XR (nevirapine) Extended-Release Tablets for Use in Combination With Other Antiretroviral Agents for Treatment of HIV-1 Infection in Adults More...

Hospitalization Not Cut by Gilead Sciences, Inc. (GILD) Heart Drug-Study More...

Market Summary

Symbol Lookup

Pfizer Inc. (PFE) Selling CAPSUGEL to KKR for $2.38 Billion, Could Set Stage For Other Divestitures More...

Pfizer Inc. (PFE) Gets Refusal-To-File Letter For Tafamidis NDA More...

Bristol-Myers Squibb Company (BMY) Interferon-Free Combo Cured Hepatitis Patients More...

GlaxoSmithKline (GSK) in Talent War Amid Emerging-Market Race With Pfizer Inc. (PFE) More...

Tranzyme Pharma Announces Pricing of Its Initial Public Offering, Raises $53.8M More...

Biotechies Need to Get Serious About Antibiotics, Where There is Money to Be Made More...

FDA Staff Views Optimer Pharmaceuticals, Inc. (OPTR) Antibiotic Favorably More...

Abbott Laboratories (ABT) Reports Positive 12-week Results From Phase 2 Study Of Hepatitis C Drug More...

Cell Therapeutics, Inc. (CTIC) Says Experimental Lymphoma Drug Offers High Response Rate More...

Actelion Ltd. (ALIOF.PK) Board Nominees Deny Sale is Main Aim More...

Men Who Lose Their Jobs at Greater Risk of Dying Prematurely, Stony Brook University Medical Center Study More...

Diabetes May Raise Cancer Risk - but Don't Panic Just Yet, National Cancer Institute Reveals More...

Researchers Link Herpes to Alzheimer's Disease; "Cold Sores" Connected to Cognitive Decline, University of New Mexico and Collaborators Find More...

Roche (RHHBY)' 'Hedgehog Inhibitor' Shrinks Basal Cancer Tumors -Study More...

Alzheimer's May Meet Insulin's Match, University at Buffalo Study More...

Most Meds Don't Help Autism, Vanderbilt University Studies Show More...

Early Work Indicates Drug Used to Treat Alcoholism May Help Those With Fragile X and Autism, Indiana University School of Medicine Study More...

Scientists Discover a Way to Kill Off Tumors in Cancer Treatment Breakthrough, Queen’s University and Almac Discovery Study More...

Arraystar Inc	Technical Sales Specialist
Singapore’s Agency for Science, Technology and Research (A*STAR)	EXECUTIVE DIRECTOR
AVEO Pharmaceuticals, Inc.	Medical Science Liaison, Oncology (West Region)
Hyperion Therapeutics	Clinical Program Manager
Genocea Biosciences, Inc.	Director of Clinical Operations

Featured Employer: AVEO Pharmaceuticals, Inc.
Science. Passion. Impact.
ONCOLOGY
AVEO Pharmaceuticals (Cambridge, MA) is moving toward realizing its vision of becoming a fully integrated cancer therapeutics company. The company’s lead product candidate tivozanib is currently in a global phase 3 clinical trial for renal carcinoma. In addition, AVEO’s proprietary cancer biology platform has produced a promising pipeline of monoclonal antibodies against high-value targets developed independently as well as in partnerships with established biotechnology companies.

www.aveopharma.com.

Show me jobs for this employer

How To Explain You Got Fired From Your Last Job and Other Job Seeking Hurdles More...

How Many Thank-You E-mails Land the Job? More...

7 Things Not to Say During a Job Interview More...

Resumes Without Cover Letters End Up at the Bottom of the Stack More...

Use the Side Door to Enter This Tough Job Market More...

How to Protect Your Identity When Applying for a Job More...

Advanced Salary Negotiation Tactics That Open An Employer's Check Book More...

How to Research a Hiring Manager Before an Interview More...

10 Mistakes You're Making on Your Resume More...

Where Will You Be in Five Years? More...

Mar	APR	May
	06
2010	2011	2012